CRISPR Therapeutics’ $280 Million Equity Issuance

Walder Wyss advised CRISPR Therapeutics on the issuance. CRISPR Therapeutics AG (NASDAQ: CRSP), a Switzerland-based biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

United Playgrounds’ Acquisition of Fitzroy

Squire Patton Boggs advised Fitzroy on the deal. Strategic creative agency Fitzroy has been acquired by marketing solutions group United Playgrounds, a Standard Investment portfolio company. Award-winning...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here